Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Inngjerdingen
M. Inngjerdingen
Medicine
Immunology
Innate immune system
In vivo
Refractory
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Incidence of chronic Graft-versus-Host Disease – results from a prospective multicentre analysis of 2 cohorts
2020
A. Lelas
R. Langer
M. Rittenschober
L. Desnica
Hildegard Greinix
A. Dickinson
M. Inngjerdingen
Anita Lawitschka
Radovan Vrhovac
Dražen Pulanić
S. Klein
J.M. Middeke
M Edinger
D. Wolff
Show All
Source
Cite
Save
Citations (0)
Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers
2019
European Journal of Cancer
M. Atzler
A. Rank
M. Inngjerdingen
A. Rabe
D. Deen
R. Wang
B. Eiz-Vesper
Christoph Schmid
Helga Schmetzer
Show All
Source
Cite
Save
Citations (0)
Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells
2018
European Journal of Cancer
Christoph Schmid
M. Atzler
A. Rank
M. Inngjerdingen
A. Rabe
D. Deen
R. Wang
B. Eiz-Vesper
Helga Schmetzer
Show All
Source
Cite
Save
Citations (0)
Immunemodulation of AML-blasts with clinically approved response modifiers improves antileukemic T-cell reactivity ex vivo and leads to blast-reduction in vivo (rat-Modell)
2016
Bone Marrow Transplantation
M. Inngjerdingen
A. Rabe
D. Deen
Z. Stankova
A. Hirn
Johanna Tischer
Christoph Schmid
Helga Schmetzer
Show All
Source
Cite
Save
Citations (0)
1